Get the Stockscreener App
74.36
7.02%
4.88
After Hours:
74.37
0.01
+0.01%
Genedx Holdings Corp stock is traded at $74.36, with a volume of 768.39K.
It is up +7.02% in the last 24 hours and down -3.93% over the past month.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.
See More
Previous Close:
$69.48
Open:
$69.62
24h Volume:
768.39K
Relative Volume:
1.15
Market Cap:
$2.04B
Revenue:
$267.23M
Net Income/Loss:
$-83.50M
P/E Ratio:
-23.91
EPS:
-3.11
Net Cash Flow:
$-59.99M
1W Performance:
+3.27%
1M Performance:
-3.93%
6M Performance:
+133.62%
1Y Performance:
+2,195%
1-Day Range:
$69.62
$75.22
1-Week Range:
$66.81
$77.00
52-Week Range:
$2.85
$98.87
Genedx Holdings Corp Stock (WGS) Company Profile
Name
Genedx Holdings Corp
Sector
Industry
Phone
617 780 8742
Address
333 LUDLOW STREET, STAMFORD
Compare WGS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WGS
Genedx Holdings Corp
|
74.36 | 2.04B | 267.23M | -83.50M | -59.99M | -3.11 |
|
VEEV
Veeva Systems Inc
|
223.04 | 36.21B | 2.66B | 665.91M | 1.08B | 4.05 |
|
SOLV
Solventum Corp
|
74.02 | 12.79B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
55.52 | 10.37B | 516.85M | 174.11M | 217.38M | 0.87 |
|
HQY
Healthequity Inc
|
104.74 | 9.08B | 1.15B | 96.70M | -161.99M | 1.09 |
|
TEM
Tempus Ai Inc
|
47.64 | 7.50B | 640.44M | -743.28M | -206.93M | -11.29 |
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jul-10-24 | Initiated | Craig Hallum | Buy |
| Jun-03-24 | Resumed | Jefferies | Hold |
Genedx Holdings Corp Stock (WGS) Latest News
Institutional owners may ignore GeneDx Holdings Corp.'s (NASDAQ:WGS) recent US$427m market cap decline as longer-term profits stay in the green - Yahoo Finance
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)January 17, 2025 - BioSpace
(WGS) Technical Data - Stock Traders Daily
Assenagon Asset Management S.A. Sells 61,642 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
GeneDx (NASDAQ:WGS) Sees Unusually-High Trading VolumeWhat's Next? - MarketBeat
GeneDx (NASDAQ:WGS) Trading Down 7.2%Here's What Happened - MarketBeat
Barclays PLC Acquires 14,681 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
GeneDx Holdings: A Phenomenal Comeback With More Room To Run - Seeking Alpha
GeneDx raises Q4 adjusted gross margin view to 68% from 64% - Yahoo Finance
GeneDx Holdings (WGS) Surges 13.2%: Is This an Indication of Further Gains? - MSN
GeneDx anticipates higher-than-expected annual revenues - MSN
GeneDx Holdings Expects Strong 2024 Financial Performance - TipRanks
GeneDx forecasts strong revenue and gross margin growth By Investing.com - Investing.com South Africa
Why Have GeneDx Holdings Stocks Plummeted? - TipRanks
GeneDx forecasts strong revenue and gross margin growth - Investing.com India
GeneDx Announces Preliminary 2024 Financial Results - Business Wire
Insider Sell: Katherine Stueland Sells 51,420 Shares of GeneDx H - GuruFocus.com
Genedx CEO sells shares worth $4.86 million - Investing.com India
Genedx CEO sells shares worth $4.86 million By Investing.com - Investing.com Australia
GeneDx Holdings Corp. (NASDAQ:WGS) CFO Sells $3,331,172.92 in Stock - MarketBeat
GeneDx Holdings Corp. (NASDAQ:WGS) CEO Katherine Stueland Sells 51,420 Shares - MarketBeat
GeneDx (NASDAQ:WGS) Stock Price Down 6.3%What's Next? - MarketBeat
GeneDx Introduces New Telehealth Pathway to Expand Access to Exome Testing for Parents Seeking Answers - Business Wire
How the (WGS) price action is used to our Advantage - Stock Traders Daily
TD Cowen Boosts GeneDx (NASDAQ:WGS) Price Target to $118.00 - Defense World
GeneDx Continues its Leadership in Genomics Research, Refining Gene-Disease Relationships and Impacting Results of >22,000 Patients - Business Wire
GeneDx Holdings Corp. (NASDAQ:WGS) Looks Just Right With A 26% Price Jump - Simply Wall St
TD Cowen Forecasts Strong Price Appreciation for GeneDx (NASDAQ:WGS) Stock - MarketBeat
Genedx CEO Katherine Stueland sells shares worth $1.4 million By Investing.com - Investing.com Australia
GeneDx (NASDAQ:WGS) Hits New 52-Week HighShould You Buy? - MarketBeat
2025 investment picks - substack.com
GeneDx Holdings Corp. (NASDAQ:WGS) CEO Katherine Stueland Sells 18,006 Shares - MarketBeat
Kevin Feeley Sells 1,430 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) Stock - MarketBeat
Genedx CFO Kevin Feeley sells $108,736 in stock By Investing.com - Investing.com Australia
Genedx CFO Kevin Feeley sells $108,736 in stock - Investing.com India
Genedx CEO Katherine Stueland sells shares worth $1.4 million - Investing.com
GeneDx (NASDAQ:WGS) Stock Price Up 7.3%Time to Buy? - MarketBeat
When Will GeneDx Holdings Corp. (NASDAQ:WGS) Turn A Profit? - Simply Wall St
Principal Financial Group Inc. Acquires New Stake in GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
Principal Financial Group Inc. Invests $604,000 in GeneDx Holdings Corp. (NASDAQ:WGS) - Defense World
5 Stocks To Watch Heading Into Friday - MSN
Resources Connection, SPS Commerce And 3 Stocks To Watch Heading Into Friday - Benzinga
GeneDx Holdings Appoints Bryan Dechairo as COO - TipRanks
Genedx Holdings Corp Stock (WGS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.52%
2.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):